A 1.6-million-birth analysis finds that adoption of a 2016 trial's antibiotic protocol climbed sharply in US hospitals, with a drop in infection rates.
|Articles|October 3, 2007
Pediatric Lamisil granules get FDA nod
Lamisil oral granules are approved by the FDA for tinea capitis
Advertisement
Terbinafine (Lamisil, Novartis) oral granules have been approved for the treatment of tinea capitis in children aged four years and older. Novartis developed the new formulation in response to a written request from the FDA for the product. The granules can be sprinkled on food and are approved to be administered once daily for six weeks.
To go to the Drug Topics homepage,
Advertisement
Related to this article
New findings suggest semaglutide's benefits may extend well beyond diabetes and weight loss and into airway disease and mood disorders.
First approved for adults in 2022, the therapy is now cleared for children 12-18 with symptomatic obstructive hypertrophic cardiomyopathy.
With the inherent value medications provide in the greater health care system, Jennifer Hammons, PharmD, DrPH, argues that rural pharmacies deserve the proper recognition.
A claims analysis of 2031 patients aged 10 to 17 years found that nutrition counseling was infrequent and often began months after treatment started.
Community pharmacists offer accessible care, improve medication adherence, and build trust through education, vaccination support, and local health leadership.
Researchers compared vaccine coadministration with single-dose, sequential vaccination for the RSVPreF3 OA vaccine formulation in adults.
A study of women aged 50 to 69 years found that thrombotic risk varied by route of administration, estradiol dose, and duration of use.
Advertisement
Advertisement
Trending on Drug Topics
1
What Is HIV PrEP and Who Needs It Most?
2
Normal vs. Concerning COVID-19 Vaccine Reactions: A Pharmacist's Guide
3
Validating Fear Before Facts: A Framework for COVID-19 Hesitancy
4
Why Rural Pharmacies Are Essential Infrastructure in US Health Care
5